<html><body>
<p><b><u>Allergies</u></b></p>
<p>Allergen (clinical drug ingredient)</p>
<p>Drug/Non Drug Allergy documented on EMR</p>
<p>Reaction</p>
<p>Allergy Type</p>
<p>Onset Date</p>
<p>Status</p>
<p>All nuts (uncoded)</p>
<p>anaphylaxis</p>
<p>Allergy</p>
<p>Active</p>
<p>Environmental, seasonal (uncoded)</p>
<p>nasal congestion, rhinorrhea, HA, asthma</p>
<p>Allergy</p>
<p>Active</p>
<p>Seafood</p>
<p>Seafood (uncoded)</p>
<p>anaphylaxis</p>
<p>Allergy</p>
<p>Active</p>
<p>Levaquin</p>
<p>anaphylaxis</p>
<p>Drug Allergy</p>
<p>Active</p>
<p>atorvastatin</p>
<p>Lipitor</p>
<p>hives</p>
<p>Drug Allergy</p>
<p>Active</p>
<br/>
<p><b><u>Results</u></b></p>
<p>No Results</p>
<br/>
<p><b><u>Reason For Referral</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>REASON FOR VISIT</u></b></p>
<p>Lab review</p>
<br/>
<p><b><u>Medications</u></b></p>
<p>Medication</p>
<p>SIG (Take, Route, Frequency, Duration)</p>
<p>Notes</p>
<p>Start Date</p>
<p>End Date</p>
<p>Status</p>
<p>NexIUM 40 MG</p>
<p>1 capsule Orally Once a day</p>
<p>Unknown</p>
<p>busPIRone HCl 10 MG</p>
<p>1 tablet Orally Twice a day</p>
<p>Unknown</p>
<p>Vitamin D 50 MCG (2000 UT)</p>
<p>1 tablet Orally Once a day</p>
<p>Unknown</p>
<p>Omeprazole 40 MG</p>
<p>1 capsule 30 minutes before morning meal Orally Once a day</p>
<p>Unknown</p>
<p>Ibuprofen 800 MG</p>
<p>1 tablet with food or milk as needed Orally every 8 hrs</p>
<p>Unknown</p>
<p>Ondansetron HCl 4 MG</p>
<p>1 tablet Orally Once a day; Duration: 30 day(s)</p>
<p>PRN</p>
<p>06/11/2024</p>
<p>Unknown</p>
<p>Benzonatate 100 MG</p>
<p>1 capsule as needed Orally Three times a day</p>
<p>02/09/2024</p>
<p>Unknown</p>
<p>Levocetirizine Dihydrochloride 5 MG</p>
<p>1 tablet in the evening Orally Once a day; Duration: 30 days</p>
<p>07/18/2025</p>
<p>08/17/2025</p>
<p>Active</p>
<p>Benzonatate 100 MG</p>
<p>1 capsule as needed orally Three times a day; Duration: 14 day(s)</p>
<p>01/31/2024</p>
<p>Unknown</p>
<p>metroNIDAZOLE 1 %</p>
<p>1 application Externally Once a day; Duration: 30 days</p>
<p>07/01/2025</p>
<p>07/31/2025</p>
<p>Active</p>
<p>Repatha 140 MG/ML</p>
<p>1 mL Subcutaneous every other week; Duration: 30 days</p>
<p>05/15/2024</p>
<p>Unknown</p>
<p>Albuterol Sulfate HFA 108 (90 Base) MCG/ACT</p>
<p>1 puff as needed Inhalation every 4 hrs</p>
<p>Unknown</p>
<p>hydrOXYzine HCl 10 MG</p>
<p>1 tablet as needed Orally Once a day</p>
<p>PRN</p>
<p>Unknown</p>
<p>Singulair 10 MG</p>
<p>1 tablet Orally Once a day</p>
<p>Unknown</p>
<p>Xanax 0.5 MG</p>
<p>1 tablet Orally Twice a day</p>
<p>Unknown</p>
<p>Calcium</p>
<p>Unknown</p>
<p>Vitamin C</p>
<p>Unknown</p>
<p>methIMAzole 5 MG</p>
<p>1 tablet Orally Once a day</p>
<p>Unknown</p>
<p>Juven -</p>
<p>as directed Orally</p>
<p>Unknown</p>
<p>Lidocaine 4 %</p>
<p>1 patch as needed Externally Once a day</p>
<p>Unknown</p>
<p>Probiotic</p>
<p>Unknown</p>
<p>Theratears</p>
<p>0.25% solution</p>
<p>Unknown</p>
<p>Fluticasone Propionate 50 MCG/ACT</p>
<p>2 sprays in each nostril Nasally Once a day</p>
<p>Unknown</p>
<p>Loratadine 10 MG</p>
<p>1 tablet Orally Once a day</p>
<p>Unknown</p>
<p>Budesonide-Formoterol Fumarate 160-4.5 MCG/ACT</p>
<p>2 puffs Inhalation Twice a day</p>
<p>Unknown</p>
<br/>
<p><b><u>Immunizations</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>Social History</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>Problems</u></b></p>
<p>Problem Type</p>
<p>SNOMED Code</p>
<p>ICD Code</p>
<p>Onset Dates</p>
<p>Problem Status</p>
<p>W/U Status</p>
<p>Risk</p>
<p>Notes</p>
<p>Problem</p>
<p>Vitamin B>12< deficiency anaemia (49472006)</p>
<p>Vitamin B12 deficiency anemia, unspecified (D51.9)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Hyperprolactinemia (237662005)</p>
<p>Hyperprolactinemia (E22.1)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Hyperlipidemia (55822004)</p>
<p>Hyperlipidemia, unspecified (E78.5)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Restless legs syndrome (32914008)</p>
<p>Restless legs syndrome (G25.81)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Rheumatoid lung disease (398726004)</p>
<p>Rheumatoid lung disease with rheumatoid arthritis of unspecified site (M05.10)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Paresthesia (finding) (91019004)</p>
<p>Paresthesia of skin (R20.2)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>hypercholesterolemia (disorder) (13644009)</p>
<p>Hypercholesteremia (E78.00)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Venous insufficiency of leg (disorder) (234050002)</p>
<p>Venous insufficiency (I87.2)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Essential hypertension (59621000)</p>
<p>Hypertension, unspecified type (I10)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Hyperlipidaemia (55822004)</p>
<p>Hyperlipidemia, unspecified hyperlipidemia type (E78.5)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Claudication (63491006)</p>
<p>Claudication (I73.9)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Hypothyroidism (40930008)</p>
<p>Hypothyroidism, unspecified type (E03.9)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Asthma without status asthmaticus (55570000)</p>
<p>Asthma, unspecified asthma severity, unspecified whether complicated, unspecified whether persistent (J45.909)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Vitamin D deficiency (34713006)</p>
<p>Vitamin D deficiency (E55.9)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Anxiety (48694002)</p>
<p>Anxiety (F41.9)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Lupus anticoagulant disorder (19267009)</p>
<p>Lupus anticoagulant disorder (D68.62)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Pain at rest of bilateral lower limbs due to atherosclerosis (disorder) (12236991000119103)</p>
<p>Rest pain of both lower extremities due to atherosclerosis (I70.223)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Skin sensation disturbance (80910005)</p>
<p>Tingling of both feet (R20.2)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Burning sensation of skin (762397008)</p>
<p>Burning sensation of skin (R20.8)</p>
<p>Active</p>
<p>confirmed</p>
<br/>
<p><b><u>Vital Signs</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>Procedures</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>Encounters</u></b></p>
<p>Encounter</p>
<p>Location</p>
<p>Date</p>
<p>Provider</p>
<p>Diagnosis</p>
<p>Epic Heart And Vascular Care</p>
<p>4 HDSN VLY PROF PLZ STE B NEWBURGH, NY 12550-3157</p>
<p>07/19/2025</p>
<p>Shellene Napier-Martin</p>
<p>Leg swelling M79.89 ; Person consulting for explanation of examination or test findings Z71.2 ; Asthma, unspecified asthma severity, unspecified whether complicated, unspecified whether persistent J45.909 ; Acute sinusitis, unspecified J01.90 ; Pain in leg, unspecified M79.606 ; Abnormal level of hormones in specimens from female genital organs R87.1 ; Disorder of thyroid, unspecified E07.9 ; Hormone replacement therapy Z79.890 ; Vitamin B deficiency, unspecified E53.9 ; Raised antibody titer R76.0 ; Elevated erythrocyte sedimentation rate R70.0 ; Lupus anticoagulant disorder D68.62 ; Lyme disease A69.20 ; Hyperprolactinemia E22.1 ; Rheumatoid lung disease with rheumatoid arthritis of unspecified site M05.10 ; Hypothyroidism, unspecified type E03.9 ; Flushing R23.2 ; Hyperlipidemia, unspecified hyperlipidemia type E78.5 ; Rash and nonspecific skin eruption R21 ; Deficiency of other specified B group vitamins E53.8 ; Vitamin B12 deficiency anemia, unspecified D51.9 ; Former smoker Z87.891 ; Hypercholesteremia E78.00 ; Vitamin D deficiency E55.9 ; Claudication I73.9 ; Hypertension, unspecified type I10 ; Rest pain of both lower extremities due to atherosclerosis I70.223 ; Anxiety F41.9 ; Palpitations R00.2 ; Fatigue, unspecified type R53.83 ; Leg heaviness R29.898 ; Leg numbness R20.0 ; Blurred vision H53.8 ; Ocular pain, unspecified eye H57.10 ; Paresthesia of skin R20.2 ; Anesthesia of skin R20.0 ; Tingling of both feet R20.2 ; Decreased pedal pulses R09.89 ; Restless legs syndrome G25.81 ; Cold feet R20.9 ; Burning sensation of skin R20.8 ; Dizziness R42 and Venous insufficiency I87.2</p>
<br/>
<p><b><u>Medical Equipment</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>Assessments</u></b></p>
<p>Encounter Date</p>
<p>Diagnosis (ICD Code)</p>
<p>Treatment Notes</p>
<p>Section Notes</p>
<p>encounter date : 07/19/2025</p>
<p>Leg swelling (ICD-10 - M79.89)</p>
<p>encounter date : 07/19/2025</p>
<p>Person consulting for explanation of examination or test findings (ICD-10 - Z71.2)</p>
<p>encounter date : 07/19/2025</p>
<p>Asthma, unspecified asthma severity, unspecified whether complicated, unspecified whether persistent (ICD-10 - J45.909)</p>
<p>encounter date : 07/19/2025</p>
<p>Acute sinusitis, unspecified (ICD-10 - J01.90)</p>
<p>encounter date : 07/19/2025</p>
<p>Pain in leg, unspecified (ICD-10 - M79.606)</p>
<p>encounter date : 07/19/2025</p>
<p>Abnormal level of hormones in specimens from female genital organs (ICD-10 - R87.1)</p>
<p>encounter date : 07/19/2025</p>
<p>Disorder of thyroid, unspecified (ICD-10 - E07.9)</p>
<p>encounter date : 07/19/2025</p>
<p>Hormone replacement therapy (ICD-10 - Z79.890)</p>
<p>encounter date : 07/19/2025</p>
<p>Vitamin B deficiency, unspecified (ICD-10 - E53.9)</p>
<p>encounter date : 07/19/2025</p>
<p>Raised antibody titer (ICD-10 - R76.0)</p>
<p>encounter date : 07/19/2025</p>
<p>Elevated erythrocyte sedimentation rate (ICD-10 - R70.0)</p>
<p>encounter date : 07/19/2025</p>
<p>Lupus anticoagulant disorder (ICD-10 - D68.62)</p>
<p>encounter date : 07/19/2025</p>
<p>Lyme disease (ICD-10 - A69.20)</p>
<p>encounter date : 07/19/2025</p>
<p>Hyperprolactinemia (ICD-10 - E22.1)</p>
<p>encounter date : 07/19/2025</p>
<p>Rheumatoid lung disease with rheumatoid arthritis of unspecified site (ICD-10 - M05.10)</p>
<p>encounter date : 07/19/2025</p>
<p>Hypothyroidism, unspecified type (ICD-10 - E03.9)</p>
<p>encounter date : 07/19/2025</p>
<p>Flushing (ICD-10 - R23.2)</p>
<p>encounter date : 07/19/2025</p>
<p>Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)</p>
<p>encounter date : 07/19/2025</p>
<p>Rash and nonspecific skin eruption (ICD-10 - R21)</p>
<p>encounter date : 07/19/2025</p>
<p>Deficiency of other specified B group vitamins (ICD-10 - E53.8)</p>
<p>encounter date : 07/19/2025</p>
<p>Vitamin B12 deficiency anemia, unspecified (ICD-10 - D51.9)</p>
<p>encounter date : 07/19/2025</p>
<p>Former smoker (ICD-10 - Z87.891)</p>
<p>encounter date : 07/19/2025</p>
<p>Hypercholesteremia (ICD-10 - E78.00)</p>
<p>encounter date : 07/19/2025</p>
<p>Vitamin D deficiency (ICD-10 - E55.9)</p>
<p>encounter date : 07/19/2025</p>
<p>Claudication (ICD-10 - I73.9)</p>
<p>encounter date : 07/19/2025</p>
<p>Hypertension, unspecified type (ICD-10 - I10)</p>
<p>encounter date : 07/19/2025</p>
<p>Rest pain of both lower extremities due to atherosclerosis (ICD-10 - I70.223)</p>
<p>encounter date : 07/19/2025</p>
<p>Anxiety (ICD-10 - F41.9)</p>
<p>encounter date : 07/19/2025</p>
<p>Palpitations (ICD-10 - R00.2)</p>
<p>encounter date : 07/19/2025</p>
<p>Fatigue, unspecified type (ICD-10 - R53.83)</p>
<p>encounter date : 07/19/2025</p>
<p>Leg heaviness (ICD-10 - R29.898)</p>
<p>encounter date : 07/19/2025</p>
<p>Leg numbness (ICD-10 - R20.0)</p>
<p>encounter date : 07/19/2025</p>
<p>Blurred vision (ICD-10 - H53.8)</p>
<p>encounter date : 07/19/2025</p>
<p>Ocular pain, unspecified eye (ICD-10 - H57.10)</p>
<p>encounter date : 07/19/2025</p>
<p>Paresthesia of skin (ICD-10 - R20.2)</p>
<p>encounter date : 07/19/2025</p>
<p>Anesthesia of skin (ICD-10 - R20.0)</p>
<p>encounter date : 07/19/2025</p>
<p>Tingling of both feet (ICD-10 - R20.2)</p>
<p>encounter date : 07/19/2025</p>
<p>Decreased pedal pulses (ICD-10 - R09.89)</p>
<p>encounter date : 07/19/2025</p>
<p>Restless legs syndrome (ICD-10 - G25.81)</p>
<p>encounter date : 07/19/2025</p>
<p>Cold feet (ICD-10 - R20.9)</p>
<p>encounter date : 07/19/2025</p>
<p>Burning sensation of skin (ICD-10 - R20.8)</p>
<p>encounter date : 07/19/2025</p>
<p>Dizziness (ICD-10 - R42)</p>
<p>encounter date : 07/19/2025</p>
<p>Venous insufficiency (ICD-10 - I87.2)</p>
<p>encounter date : 07/19/2025</p>
<p>Other</p>
<p>Her</p>
<p>labs, including thyroid function, FSH, LH, CRP, ESR, rheumatoid</p>
<p>factor, estradiol, progesterone, serotonin, prolactin, triptase,</p>
<p>estrogen, lupus panel, and B12, were all within normal limits. We</p>
<p>will continue monitoring her energy levels and hormone balance. She</p>
<p>is advised to maintain her current medications. All questions and</p>
<p>concerns answered and addressed. Heart healthy diet and healthy</p>
<p>lifestyle modifications were encouraged and endorsed. Patient is in</p>
<p>agreement with the plan.</p>
<p>Patient was informed of the telemedicine visit by our office staff. Telemedicine was described in detail to the patient as the use of synchronous video and audio communication to provide clinical care from a distance. A telemedicine visit can provide the same medical standard of care for specific conditions. The patient was informed that the practice staff located at the provider's office would assist in carrying out any recommendations and clinical care.</p>
<p>Patient Location: Home</p>
<p>Lack of strict HIPPA Rules. Patient expressed verbal interest in the telemedicine visit and granted consent to proceed.</p>
<br/>
<p><b><u>Plan Of Treatment</u></b></p>
<p>Treatment Notes</p>
<p>Assessment</p>
<p>Notes</p>
<p>Other</p>
<p>Her</p>
<p>labs, including thyroid function, FSH, LH, CRP, ESR, rheumatoid</p>
<p>factor, estradiol, progesterone, serotonin, prolactin, triptase,</p>
<p>estrogen, lupus panel, and B12, were all within normal limits. We</p>
<p>will continue monitoring her energy levels and hormone balance. She</p>
<p>is advised to maintain her current medications. All questions and</p>
<p>concerns answered and addressed. Heart healthy diet and healthy</p>
<p>lifestyle modifications were encouraged and endorsed. Patient is in</p>
<p>agreement with the plan.</p>
<p>Patient was informed of the telemedicine visit by our office staff. Telemedicine was described in detail to the patient as the use of synchronous video and audio communication to provide clinical care from a distance. A telemedicine visit can provide the same medical standard of care for specific conditions. The patient was informed that the practice staff located at the provider's office would assist in carrying out any recommendations and clinical care.</p>
<p>Patient Location: Home</p>
<p>Lack of strict HIPPA Rules. Patient expressed verbal interest in the telemedicine visit and granted consent to proceed.</p>
<p>Next Appt</p>
<p>Details</p>
<p>Follow Up: As scheduled, Reason:</p>
<p>Provider Name:MARION HAYES, 09/16/2025 09:15:00 AM, 528 East Main St, MIDDLETOWN, NY, 10940-2632, 877-374-2362</p>
<p>Provider Name:RISHI BAJAJ, 09/19/2025 04:00:00 PM, 528 East Main St, MIDDLETOWN, NY, 10940-2632, 877-374-2362</p>
<br/>
<p><b><u>Goals Section</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>Health Concerns</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>Insurance Providers</u></b></p>
<p>Payer Name</p>
<p>Payer Address</p>
<p>Payer Phone</p>
<p>Subscriber Number</p>
<p>Group Number</p>
<p>Insured Name</p>
<p>Patient Relationship to Insured</p>
<p>Coverage Start Date</p>
<p>Coverage End Date</p>
<p>Aetna Health</p>
<p>PO BOX 981106 EL PASO, TX 79998-1107</p>
<p>102026205700</p>
<p>Diaz, Maria</p>
<p>Self - patient is the insured</p>
<p>Affinity by Molina Healthcare NY</p>
<p>PO BOX 22615 LONG BEACH, CA 90801-5637</p>
<p>800-223-7242</p>
<p>AQ06345C</p>
<p>Diaz, Maria</p>
<p>Self - patient is the insured</p>
<p>Medicare of New York  Downstate  J13</p>
<p>PO BOX 6178 INDIANAPOLIS, IN 462066178</p>
<p>866-837-0241</p>
<p>1AK5QK4DM86</p>
<p>Diaz, Maria</p>
<p>Self - patient is the insured</p>
<p>Medicaid of New York</p>
<p>PO BOX 4601 RENSSELAER, NY 121444602</p>
<p>AQ06345C</p>
<p>Diaz, Maria</p>
<p>Self - patient is the insured</p>
<br/>
<p><b><u>History and Physical Notes</u></b></p>
<p>HPI (History of Present Illness)</p>
<p>Category</p>
<p>Sub-Category</p>
<p>Detail</p>
<p>Notes</p>
<p>Category Notes</p>
<p>Transition of Care</p>
<p>This is a 63-year-old female, former smoker, with a history of asthma, anemia, HLD, hypothyroidism and anxiety, who presents today for a cardiovascular follow-up via TMV for lab review. She reports ongoing fatigue, with some improvement after B12 injections. She remains on hormone replacement therapy. She denies any chest pain, dyspnea, dizziness, or syncopal episodes.</p>
<p>Venous reflux study: Significant reflux in bilateral GSV</p>
<p>Echocardiogram: LVEF 55-60%, mild pulmonary hypertension with PASP of 30 mmHg.</p>
<p>BLE arterial doppler: Significant stenosis with possible infrapopliteal bilateral stenosis.</p>
<p>Carotid doppler:  Mild plaque.</p>
<p>AAA screen: Mild-to-moderate plaque, no significant evidence of abdominal uretic aneurysm.</p>
<p>Peripheral angiogram; 02/12/25; right femoral artery access revealing RSFA 40% stenosis and LSFA 50% stenosis.</p>
<p>BLE arterial doppler: Patent flow.</p>
<p>Venous reflux:  Mild reflux and no significant DVT.</p>
<p>Her labs, including thyroid function, FSH, LH, CRP, ESR, rheumatoid factor, estradiol, progesterone, serotonin, prolactin, triptase, estrogen, lupus panel, and B12, were all within normal limits. We will continue monitoring her energy levels and hormone balance. She is advised to maintain her current medications. All questions and concerns answered and addressed. Heart healthy diet and healthy lifestyle modifications were encouraged and endorsed. Patient is in agreement with the plan.</p>
<br/>
</body></html>
